科研之友
微信
新浪微博
Facebook
分享链接
摘要
Cross-presentation of tumor antigens represents a key pathway in antitumor immune responses that can be exploited to synergize not only with the already prominent "checkpoint blockade," but also with newer attempts to use T-cell stimulatory monoclonal antibodies in immunotherapy.
- 出版日期2016-1
